From the Section of Interventional Radiology, Dept of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar St, PO Box 208042, Room TE-2, New Haven, CT 06520 (A.S., S.A.); Dept of Rad/Body MRI, Dept of Radiology, Stanford Univ, Lucas Ctr, Stanford, Calif (P.G.); Dept of Urology, Univ of Washington School of Medicine, Seattle, Wash (G.R.S., A.W.); Dept of Radiological Sciences, MRgFUS and Cardiovascular Imaging Unit, Sapienza Univ of Rome, School of Medicine, Rome, Italy (A.N.); Institut Khuab for Interventional Oncology, Comprehensive Tumor Ctr Barcelona, Barcelona, Spain (J.V.J.); Dept of Interventional and Diagnostic Radiology, Univ of California Los Angeles, Los Angeles, Calif (S.S.R.); Abdominal and Cross-Sectional Interventional Radiology, Dept of Radiology, Univ of Michigan School of Medicine, Ann Arbor, Mich (M.M.L.); Dept of Medical Imaging, Univ Health Network-Mount Sinai Hosp-Women's College Hosp, Univ of Toronto, Toronto, Canada (S.G.); Inst of Urology, Univ of Southern California-USC School of Medicine, Los Angeles, Calif (A.A.); and Dept of Radiology, Hosp of the Univ of Pennsylvania, Philadelphia, Pa (K.M.S.).
Radiographics. 2022 Oct;42(6):E182-E183. doi: 10.1148/rg.220044.
US and MRI-guided therapeutic US (TUS) can aid in the treatment of prostate, liver, and pancreatic cancer, as well as uterine fibroids and osseous metastases, and understanding the selection and optimization of treatment strategies is essential to furthering TUS advances and innovations.
美国和 MRI 引导的治疗性超声（TUS）可辅助治疗前列腺癌、肝癌、胰腺癌以及子宫肌瘤和骨转移，了解治疗策略的选择和优化对于推进 TUS 的进步和创新至关重要。
